ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,282.54
      -0.72%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Equillium Inc (EQ)

      7. Equillium Inc (EQ) News

      EQ

      Equillium (EQ)

      Equillium Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:EQ
      DateTimeSourceHeadlineSymbolCompany
      04/03/20248:00AMBusiness WireEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EQEquillium Inc
      04/01/20248:00AMBusiness WireEquillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus NephritisNASDAQ:EQEquillium Inc
      03/25/20244:01PMBusiness WireEquillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical HighlightsNASDAQ:EQEquillium Inc
      03/22/20248:00AMBusiness WireEquillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational ConferenceNASDAQ:EQEquillium Inc
      03/08/20245:35PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EQEquillium Inc
      03/08/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      02/23/20245:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      02/23/20245:09PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EQEquillium Inc
      02/22/20246:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      01/03/20246:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
      01/03/20246:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
      01/03/20246:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
      12/21/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      12/21/20238:00AMBusiness WireEquillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac DiseaseNASDAQ:EQEquillium Inc
      11/20/202311:23AMPR Newswire (US)EQ Bank Card launches in Québec as Carte Banque EQNASDAQ:EQEquillium Inc
      11/20/202311:23AMPR Newswire (Canada)EQ Bank Card launches in Québec as Carte Banque EQNASDAQ:EQEquillium Inc
      11/13/20239:00AMBusiness WireEquillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of RheumatologyNASDAQ:EQEquillium Inc
      11/08/20234:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQEquillium Inc
      11/08/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      11/08/20234:01PMBusiness WireEquillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:EQEquillium Inc
      11/06/20238:00AMBusiness WireEquillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of NephrologyNASDAQ:EQEquillium Inc
      10/19/20238:00AMBusiness WireEquillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of RheumatologyNASDAQ:EQEquillium Inc
      10/16/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      10/16/20238:00AMBusiness WireEquillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics SymposiumNASDAQ:EQEquillium Inc
      10/05/20235:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      10/05/20235:23PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EQEquillium Inc
      10/03/20238:00AMBusiness WireEquillium to Host Analyst & Investor DayNASDAQ:EQEquillium Inc
      10/02/20238:00AMBusiness WireEquillium to Present at the JonesTrading 2023 Healthcare SummitNASDAQ:EQEquillium Inc
      09/20/20238:00AMBusiness WireEquillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event ConferencesNASDAQ:EQEquillium Inc
      08/30/20238:00AMBusiness WireEquillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor ConferenceNASDAQ:EQEquillium Inc
       Showing the most relevant articles for your search:NASDAQ:EQ